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Aim. This study aimed to assess the antioxidant activity of quercetin (Q) in an experimental model of cirrhosis induced by CCl4
inhalation. Materials and Methods. We used 25 male Wistar rats (250g) that were divided into 3 groups: control (CO), CCl4,a n d
CCl4 +Q .T h er a t sw e r es u b j e c t e dt oC C l 4 inhalation (2x/week) for 16 weeks, and they received phenobarbital in their drinking
water at a dose of 0.3g/dL as a P450 enzyme inducer. Q (50mg/Kg) was initiated intraperitoneally at 10 weeks of inhalation and
lasted until the end of the experiment. Statistical analysis was by ANOVA Student Newman-Keuls (mean ± SEM), and diﬀerences
were considered statistically signiﬁcant when P<0.05. Results. After treatment with quercetin, we observed an improvement
in liver complications, decreased ﬁbrosis, as analyzed by picrosirius for the quantiﬁcation of collagen, and decreased levels of
matrix metalloproteinase 2 (MMP-2) compared with the CCl4 group. It also reduced oxidative stress, as conﬁrmed by the decrease
of substances reacting to thiobarbituric acid (TBARS), the increased activity of antioxidant enzymes, and the reduced glutathione
ratioandglutathionedisulﬁde(GSH/GSSG).Conclusion.Wesuggestthattheuseofquercetinmightbepromisingasanantioxidant
therapy in liver ﬁbrosis.
1.Introduction
Cirrhosis is an advanced stage of liver ﬁbrosis characterized
by septae and nodule formation and altered blood ﬂow. It
occurs because of the synthesis and excessive deposition of
extracellular matrix (ECM) in the space of Disse along with
insuﬃcient ECM degradation, leading to a distortion of the
architecture and a progressive reduction of hepatic function
[1].
Wound healing is the normal response of tissue to an
injury ,andliverﬁbrosisoccursasaresultofrepeatedcyclesof
injuryandrepair.Moreover,chronicpersistentinﬂammation
typically precedes ﬁbrosis. Chronic liver injuries activate
and transform quiescent hepatic stellate cells (HSCs) into
activated myoﬁbroblasts, which is the central pathogenic
mechanism of ﬁbrotic disorders [2].
The development of cirrhosis is usually associated with
oxidative stress and lipid peroxidation (LPO) [3]. In this2 ISRN Gastroenterology
study, we used the carbon tetrachloride (CCl4) inhalation
model of cirrhosis in theratbecauseithasseveralsimilarities
with human cirrhosis [4]. CCl4, a widely used solvent in
chemical industries, is one of the main pathways for the
exposure and absorption of volatile chemicals that may be
environmental contaminants, and it is well known for its
hepatic and renal toxic actions. The metabolism of CCl4
into trichloromethyl (CCl3•) and peroxy trichloromethyl
(•OOCCl3) free radicals has been reported to cause hepato-
toxic eﬀects, like ﬁbrosis, steatosis, necrosis, and hepatocar-
cinoma [3].
Much eﬀort has been devoted to developing new treat-
ments for this disease. The only treatment currently available
for severe end-stage liver disease is orthotopic liver trans-
plantation [5].
Some compounds that have been studied as possible
protectors against liver cirrhosis are known for their anti-
inﬂammatory and antioxidant properties. Plants contain nu-
merous polyphenols, which have been shown to reduce in-
ﬂammation and thereby to increase resistance to disease
[6]. Quercetin (Q), a polyphenolic ﬂavonoid compound
present in large amounts in vegetables, fruits, and tea, ex-
hibits its therapeutic potential against many diseases, includ-
ing hepatoprotection and the inhibition of liver ﬁbrosis [7–
9]. It contains a number of phenolic hydroxyl groups, which
have strong antioxidant activity [10, 11]. The average intake
varies between countries but is approximately 23mg/day
[10].
By increasing the endogenous antioxidant defenses,
ﬂavonoids can modulate the redox state of organisms. The
major endogenous antioxidant systems include superoxide
dismutase (SOD), catalase (CAT), glutathione reductase
(GR), and glutathione peroxidase (GPx), which is essential
for the detoxiﬁcation of lipid peroxides [8, 12].
Therefore, using the carbon tetrachloride-induced liver
injury model, we investigated the protective actions of the
ﬂavonoid quercetin on the progression of ﬁbrosis and on
parameters of oxidative stress.
2.MaterialsandMethods
2.1. Animal Experiments and Drug Treatment. Male Wistar
rats weighing 250–300g were used. The animals were caged
at22◦Cwith12-hourlight-darkcyclesandfreeaccesstofood
and water until the experiments were performed. All exper-
iments were performed according to the Guiding Principles
for Research Involving Animals (NAS) and the Committee of
Research and Ethics in Health of the Research and Postgrad-
uate Group of the Hospital de Cl´ ınicas de Porto Alegre.
Experimental animals were randomly divided into a
control group (n = 5), a cirrhotic group treated with CCl4
for 16 weeks (n = 1 0 ) ,a n daC C l 4 + quercetin group treated
with CCl4 for 16 weeks and with quercetin from the 10th to
16th week (n = 10). A control group treated with quercetin
was not necessary because previous studies by our group
had demonstrated that it does not produce a signiﬁcant
diﬀerence compared to control animals [13].
For P450 enzymatic induction, phenobarbital (0.3g/L)
was added to the animal’s drinking water seven days before
the ﬁrst inhalation and throughout the experiment. The
CCl4 group was exposed to inhaled CCl4 twice a week (on
Mondays and Fridays) inside an inhalation chamber that
measured 65 × 26 × 21cm. CCl4 was placed in a glass
container (humidiﬁer) attached to an air compressor and
released into the chamber at a ﬂow rate of 1L/min. In the
ﬁrst three sessions, the length of gas exposure was 30s, and
the animals remained inside the chamber for another 30s,
while the compressor was turned oﬀ (waiting time). In the
fourthsession,thelengthofgasadministrationwasincreased
to 1 minute, followed by another minute in the waiting
mode.Subsequently,thelengthofgasadministrationandthe
waiting period in the chamber were increased by 30s every
three sessions, up to a peak of 5min at 16 weeks, according
to the method adapted from Cremonese et al. [14].
Quercetin (Sigma) was administered i.p. at a dose of
50mg/kg/day [9, 13]. It was initiated at the 10th week, when
histological analyses and liver function tests indicated that
the animals were already cirrhotic, and was carried out until
the date of sacriﬁce [4].
After 24 hours from the last CCl4 inhalation, the animals
were anesthetized with 1% xylasine and 10% ketamine,
and then we collected blood samples from the retro-orbital
plexus. Later, the livers were removed, washed with saline,
and divided into sections. A portion was preserved in 4%
formalin for histological examination. The rest was frozen at
−80◦C for later analysis.
2.2. Serum Biochemical Analysis. Serum activities of aspar-
tate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (AP), and total bilirubin (BT)
were measured with routine laboratory methods of the
Hospital de Cl´ ınicas de Porto Alegre.
2.3. Histological Analysis. For histological examination, a
piece of the liver from all animals was trimmed and ﬁxed
by immersion in 10% buﬀered formalin for 24 hours. The
blocks were dehydrated in a graded series of ethanol and
embedded in paraﬃn wax. Serial 3mm sections were stained
withhematoxylinandeosinorpicrosirius.Fivesectionsfrom
each sample were analyzed by two independent pathologists
who had no prior knowledge of the animal groups.
2.4. Collagen Quantiﬁcation. Collagen was determined by
estimating the hydroxyproline content, an amino acid
characteristic of collagen. Liver sections of 100mg were
hydrolyzed in 6mol/L HCl for 16h at 110◦C and evaporated
to dryness to remove the acid. The residue, dissolved
in distilled water, was mixed with 50% isopropanol and
chloramine-T solution and left for 10min at room tempera-
ture.Finally,p-dimethylaminobenzaldehydein60%perchlo-
r i ca c i dw a sa d d e da n dh e a t e dt o6 0 ◦Cf o r2 5m i n[ 15]. The
absorbance was measured at 560nm. Hydroxyproline levels
were calculated based on standard curves of 4-hydroxy-1-
proline and expressed as μg/mg protein.
2.5. Oxidative Damage Determination. Frozen tissue from
each rat was homogenized in ice-cold phosphate buﬀer
(140mM KCl, 20mM phosphate, pH 7.4) and centrifuged atISRN Gastroenterology 3
3,000rpm for 10 minutes. Oxidative stress was determined
by measuring the concentration of aldehydic products
(MDA) by thiobarbituric acid reactive substances (TBARSs)
[16]. Spectrophotometric absorbance of the supernatant at
535nm was determined.
2.6. Antioxidant Enzyme Activity
2.6.1. Superoxide Dismutase (SOD). Cytosolic superoxide
dismutase (SOD) (EC 1.5.1.1) was assayed at 30◦C according
to Misra and Fridovich [17]. The auto-oxidation rate of
epinephrine, which is progressively inhibited by increasing
amounts of SOD in the homogenate, was monitored spec-
trophotometrically at 560nm. The amount of enzyme that
inhibited 50% of epinephrine auto-oxidation was deﬁned as
1Uo fS O Da c t i v i t y .
2.6.2. Catalase (CAT). Catalase activity was determined by
measuring the decrease in absorption at 240nm in a reaction
medium containing 50mM phosphate buﬀer saline (pH 7.2)
and 0.3M hydrogen peroxide [18]. The enzyme activity was
assayed spectrophotometrically at 240nm.
2.6.3. Glutathione Peroxidase (GPx). The glutathione per-
oxidase (GPx) activity was determined by the oxidation
rate of NADPH in the presence of reduced glutathione
and glutathione reductase [19]. Sodium azide was added to
inhibit catalase activity. The GPx activity was measured with
a spectrophotometer at 340nm.
2.7. Measurement of Intracellular Reduced Glutathione/Oxi-
dized Glutathione (GSH/GSSG). GSH and GSSG measure-
ments were made according to the adapted method from
Kolberg et al. [20]. Liver sections were rinsed twice with
PBS and disrupted in 200mL of 5% (w/v) metaphospho-
ric acid on ice. After centrifugation (16,000xg, 2min at
room temperature), cell lysates were spectrophotometrically
(415nm) assayed on a microplate reader by modiﬁcation
of the 5,50-dithiobis(2-nitrobenzoic acid) (DTNB)/GSSG
reductaserecyclingmethodusingtheN-ethylmaleimidecon-
jugating technique for GSSG sample preparation. Samples
(10mL) for both GSH and GSSG determinations were
assayed in a 105μL ﬁnal volume in 96-well polystyrene
plates at 37◦C in the presence of 10mM DTNB, 0.17mM β-
NADPH (dissolved in 0.5% (w/v) NaHCO3 as a stabilizing
agent), and 0.5 U/mL GSSG reductase.
2.8. Western Blot. Protein extraction and western blotting
wereperformedasdescribedelsewhere[21].Themembranes
were incubated with anti-MMP-2 polyclonal antibody (sc-
8853, Santa Cruz Biotechnology). Binding to the primary
antibody was detected through rabbit anti-immunoglobulin
bound to HRP (DAKO A/S, Glostrup, Denmark). Protein
detection was performed by chemiluminescence using a
commercial kit ECL (Amersham Pharmacia Biotech, Little
Chalfont, Great Britain) exposing the membrane to this
commercial mixture for one minute. A cassette tape was
subsequently introduced with developing ﬁlm (Amersham
Hyperﬁlm ECL, UK) for about 2 minutes.
Table 1: Eﬀect of quercetin on hepatic enzymes in CCl4-induced
hepatic injury.
Parameters
Experimental groups
CO CCl4 CCl4 +Q
AST (U/L) 119.2 ± 10.1 488.6 ± 61.7a 256.5 ± 34.3
ALT (U/L) 35.7 ± 3.6 235.2 ± 17.4a 165.9 ± 38.7b
AP (U/L) 66.7 ± 5.0 237.6 ± 18.5a 167.6 ± 17.7b
BT (U/L) 0.3 ± 0.0 0.8 ± 0.1a 0.5 ± 0.08
Results represent mean ± S.E.
aSigniﬁcant diﬀerence between CCl4 group and groups CO and CCl4 +Q ,
considering P<0.05.
bSigniﬁcant diﬀerence between the CCl4 +Q group and group CO, consid-
ering P<0.05.
After washing the ﬁlm, the bands were quantiﬁed by
densitometry using program Scion Image 4.02 for Windows
(Scion Corporation, Frederick, USA), with results being
expressed in relation to control percentage (100%).
2.9. Statistical Analysis. The results were expressed as
mean ± SEM. The data were compared by analysis of vari-
ance (ANOVA); when the analysis indicated the presence
of a signiﬁcant diﬀerence, the means were compared with
the Student Newman-Keuls test. Signiﬁcance was accepted at
P<0.05.
3. Results
3.1. Serum Biochemical Analysis. After 16 weeks of CCl4 ex-
posure, the animals showed important alterations in enzyme
markers of hepatic injury (Table 1). The CCl4-treated group
showed a signiﬁcant increase in serum total bilirubin
and hepatic marker enzymes. However, the intraperitoneal
administration of quercetin at 50mg/kg attenuated this
e l e v a t i o no fA S T ,A L T ,A L P ,a n dB T .
3.2. Histological Analysis. The histological analysis of liver
tissue from animals in the control group (CO) showed a nor-
mal architecture of the parenchyma (Figure 1(a)). Animals
with CCl4 exposure showed a loss of the normal architecture
with the presence of regenerative nodules, cellular necrosis,
and ﬁbrosis (Figure 1(b)). In contrast, necrosis and ﬁbrosis
were minimal in animals from groups treated with quercetin
(Figure 1(c)).
3.3. Collagen. Fibrosis, which is the ﬁnal result of prolonged
liver injury, was quantiﬁed by hydroxyproline analysis and
expressed as liver collagen content (Figure 2). The colla-
gen content was signiﬁcantly higher in the CCl4-treated
group. This eﬀect was partially but signiﬁcantly reduced by
quercetin.
3.4. Lipid Peroxidation. Oxidative stress resulting from the
metabolism of CCl4 in the liver plays a critical role in damag-
ing the liver and promoting hepatic ﬁbrogenesis. The MDA
level was signiﬁcantly higher in liver homogenates of CCl4-
intoxicated rats compared with the control group (Table 2).
Treatment with quercetin signiﬁcantly reduced these levels.4 ISRN Gastroenterology
(a) (b) (c)
Figure 1: Histological analysis of liver sections by picrosirius staining. (a) Control rat liver section (100x); (b) cirrhotic rat (CCl4)l i v e r
section (100x); (c) cirrhotic rat treated with Q (CCl4 + Q) liver section (100x).
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Figure 2: Medium values of collagen in the liver from diﬀerent
groups. aSigniﬁcant diﬀerence between the CCl4 group and the CO
and CCl4 + Q groups (P<0.01). bSigniﬁcant diﬀerence between
the CCl4 + Q group and the CO group (P<0.05).
Table 2: Eﬀects of quercetin (Q) on lipid peroxidation and on
antioxidant enzyme activities in CCl4-induced hepatic injury.
Parameters
Experimental groups
CO CCl4 CCl4 +Q
TBARS (nmol/mg
protein) 0.19 ±0.001 0.37 ±0.02a 0.28 ±0.02b
SOD (U SOD/mg
protein) 3.86 ±0.28 1.41 ±0.22a 3.36 ±0.29
CAT (p mol/mg
protein) 0.62 ±0.04 0.27 ±0.02a 0.55 ±0.02
GPx (mmol/min/mg
protein) 0.27 ±0.02 0.19 ±0.01a 0.23 ±0.01
GSH (mmol/mg
protein) 362.1 ±46.63 230.66±35.09a 371.6 ±33.8
GSSG (nmol/mg
protein) 40.63 ±1.87 84.46 ±3.45a 49.96 ±3.74
GSH/GSSG (Ratio) 8.91 ±1.06 2.74 ±0.42a 7.43 ±0.80
Results represent mean ± S.E.
aSigniﬁcant diﬀerence between CCl4 group and groups CO, CCl4 +Q ,
considering P<0.05.
bSigniﬁcantdiﬀerencebetweenCCl4 +QgroupandgroupsCO,considering
P< 0.05.
3.5. Antioxidant Enzymes. CCl4 toxicity resulted in a marked
reduction of SOD, CAT, and GPx activities in liver tissues
compared with the control group (Table 2). Treatment
with quercetin signiﬁcantly reestablished the levels of these
antioxidant enzymes.
The hepatic GSH concentration decreased signiﬁcantly
after CCl4 treatment, and this decrease was attenuated by
quercetin.Concomitantly,theGSSGconcentrationincreased
in the livers of CCl4-treated animals. The ratio of GSH to
GSSH decreased when compared with the control group
after CCl4 injection, and quercetin signiﬁcantly restored this
decrease at a dose of 50mg/kg for 16 weeks (Table 2).
3.6. Matrix Metalloproteinase 2 (MMP-2) Expression. Matrix
Metalloproteinase 2 (MMP-2) increased signiﬁcantly after
CCl4 treatment, and a decreased of protein expression was
observed after treatment with quercetin of 50mg/kg for 16
weeks (Figure 3).
4. Discussion
CCl4 is widely used to induce hepatic ﬁbrosis and cirrhosis
in animal models. Furthermore, the liver signs observed in
rats due to chronic stimulation with CCl4 are similar to
thosefoundincirrhoticpatients[4].Oxidativestressplaysan
important role in the development of hepatic ﬁbrosis acting
on diﬀerent cell types and in diﬀerent signaling pathways.
Consequently, antioxidants, particularly those of plant ori-
gin, have emerged as potent antiﬁbrotic agents [8, 9]. In
this study, hepatic ﬁbrosis was successfully induced by CCl4
inhalation for 16 weeks. Through this hepatic ﬁbrosis model,
theeﬀectsofquercetinonhepaticﬁbrosisinducedbyCCl4 in
rats were examined, and the treatment was initiated 8 weeks
after the initiation of CCl4 inhalation. The ﬂavonoid was
administeredatadosepreviouslydescribedtohavebeneﬁcial
eﬀects in rats with biliary obstruction [9, 13]. Quercetin
spreads in the cell membrane and acts as a scavenger or
obstructs the chain reaction of free radicals formed, thereby
decreasing lipid peroxidation [22]. Similar eﬀects were also
obtained after the use of the ﬂavonoid quercetin in rats
in models of cirrhosis induced by intraperitoneal carbon
tetrachloride [7] and by biliary obstruction [13].
AST and ALT are enzymes that are sensitive to hepatocel-
lular injury. The release of large quantities of these enzymes
in the bloodstream is associated with centrilobular necrosis,
degeneration, and reduced performance status of the liver
[23]. In this study, we observed a signiﬁcant increase in theISRN Gastroenterology 5
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Figure 3: Medium values of matrix metalloproteinase 2 (MMP2)
expression from the diﬀerent studied groups. aSigniﬁcant diﬀerence
between the CCl4 group and the CO and CCl4 + Q groups (P<
0.05). bSigniﬁcant diﬀerence between the CCl4 + Q group and the
CO group (P<0.05).
s e r u ml e v e l so fA S T ,A L T ,A L P ,a n dB Ta f t e rC C l 4 inhalation.
The decrease of the serum enzymes AST, ALT, ALP, and BT
after treatment with quercetin demonstrated its antioxidant
potential and its hepatoprotective eﬀect.
Thehistologicalﬁndingsrevealedseverelivercelldamage
in rats after the inhalation of CCl4, supporting the observed
changes in biochemical assays. The presence of necrotic foci,
ﬁbrotic nodules, inﬁltration of lymphocytes, steatosis, and
changes in liver cells are characteristics after intoxication
with CCl4 [24]. Treatment with quercetin decreased necrosis
and ﬁbrosis. This can be considered an expression of the
functional improvement of hepatocytes. These data are con-
sistent with other studies of cirrhosis that used substances
with antioxidant power, like quercetin [13], silymarin [25],
and curcumin [6].
In this study, traditional methods of assessing hepatic
ﬁbrosis, such as the quantiﬁcation of hydroxyproline content
and histological analysis, were performed to determine the
eﬀects of quercetin on liver cirrhosis induced by CCl4.T h e
determination of hydroxyproline content in liver tissue is
regarded as a good method to quantify ﬁbrosis and to
evaluate the eﬃcacy of new antiﬁbrotic agents [26]. In this
study, the exposure to CCl4 signiﬁcantly increased the hy-
droxyproline content in the liver. This increase in collagen
deposition was reduced after treatment with quercetin,
demonstrating its eﬀectiveness on liver ﬁbrogenesis.
In addition to the eﬀects of increased synthesis of col-
lagen induction of cirrhosis also showed an increased ex-
pression of the enzyme matrix metalloproteinase 2 (MMP-
2). The key enzymes in the degradation of ﬁbrillar collagens
are matrix metalloproteinase (MMP)-1 in humans and
MMP-13 in rodents [27, 28]. However, during ﬁbrogenesis,
the expression of MMP-1 or MMP-13 is very limited,
whereas that of MMP-2 increases [29]. Our study showed
a reduction in the expression of MMP-2 after treatment
with quercetin and these results are consistent with an in
vitro study that demonstrated decreased secretion of matrix
metalloproteinases (MMP-2 and MMP-9) after a 72-hour
treatment with quercetin [30].
MDA is the main product of lipid peroxidation, and its
concentration is generally presented as the total level of lipid
peroxidation products [31]. It has been shown that MDA
can activate stellate cells that produce collagen. MDA was
analyzed by the TBARS assay, and its level was signiﬁcantly
higher in the CCl4-intoxicated group compared with the
others. The increase in LPO could have caused the loss
of structure and integrity of the cell membrane. Quercetin
treatment signiﬁcantly reduced the TBARS levels in liver
homogenates.
Several studies have found increased LPO in rats treated
with CCl4, whereas the activities of enzymes in the liver were
decreased [7, 32] also to those found in this study. Free-
radical scavenging enzymes, such as superoxide dismutase
(SOD), protect the biological systems from oxidative stress.
The current study showed a signiﬁcant decrease in SOD
activity in rats with CCl4-induced cirrhosis. On the other
hand, there was a signiﬁcant increase in SOD activity in rats
treated with quercetin. Our results indicate that treatment
with quercetin acts against free radicals formed during the
metabolism of CCl4 by restoring the levels of the antioxidant
enzymes SOD, CAT, and GPx and reducing LPO.
While there are several biochemical markers of oxidative
stress, the ratio of reduced GSH/GSSG has been widely used
as a marker of the redox state because of its sensitivity,
reliability, and abundance. GSH is the main endogenous
antioxidant and is responsible for the maintenance of the
intracellularredoxbalance,detoxiﬁcationofxenobiotics,and
reactive oxygen species [33]. The reduction of GSH in the
liver, observed in this study, may be caused by the direct
requisition of GSH by GPx to scavenge the production of
free radicals formed by the metabolism of CCl4. In this
study, the administration of quercetin not only increased the
levels of total hepatic GSH but also signiﬁcantly improved
the ratio of GSH/GSSG in the liver. Several studies indicate
that quercetin has the ability to increase the GSH/GSSG and,
consequently, decreases cellular oxidative damage [34].
A possible explanation forthese ﬁndings is thatquercetin
not only acts as a direct scavenger of reactive oxygen species
but may also exert actions on endogenous antioxidant
defenses by modulating the intracellular signaling systems.
This protection may be the result of a variety of mechanisms,
including decreasing oxidative stress due to the sequestration
of free radicals, promoting cell survival by modulating intra-
cellularsignals,anddecreasingthetoxicityofxenobioticsand
carcinogens by regulating gene expression or the activity of
the cytochrome P450 enzymes [35].6 ISRN Gastroenterology
In summary, administration of quercetin seems to have
a protective role in liver of rats with experimentally induced
cirrhosis, as demonstrated by the reduction of ﬁbrosis and
oxidative stress.
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